| 4 | Statement of changes in beneficial owner... | Kalaris Therapeutics, Inc. | Donnelley Financial Solutions /fa/ | 06/04/2026 | |
| 4 | Statement of changes in beneficial owner... | Adamis Anthony P | Donnelley Financial Solutions /fa/ | 06/04/2026 | |
| 4 | Statement of changes in beneficial owner... | Kalaris Therapeutics, Inc. | Donnelley Financial Solutions /fa | 04/11/2025 | |
| 4 | Statement of changes in beneficial owner... | Adamis Anthony P | Donnelley Financial Solutions /fa | 04/11/2025 | |
| 3 | Initial statement of beneficial ownershi... | Kalaris Therapeutics, Inc. | Donnelley Financial Solutions /fa | 03/18/2025 | |
| 3 | Initial statement of beneficial ownershi... | Adamis Anthony P | Donnelley Financial Solutions /fa | 03/18/2025 | |
| 4 | Statement of changes in beneficial owner... | Kalaris Therapeutics, Inc. | Donnelley Financial Solutions /fa | 03/18/2025 | |
| 4 | Statement of changes in beneficial owner... | Adamis Anthony P | Donnelley Financial Solutions /fa | 03/18/2025 | |
| 144 | Filing for proposed sale of securities u... | Eyepoint Pharmaceuticals, Inc. | Morgan Stanley Smith Barney Llc Executive Services /fa | 10/23/2024 | |
| 144 | Filing for proposed sale of securities u... | Adamis Anthony P | Morgan Stanley Smith Barney Llc Executive Services /fa | 10/23/2024 | |
| Load More |